M3P unit has been created on January the first, 2023. Our team is also part of the UMR Paris-Saclay-Versailles St-Quentin University – INSERM U1173. We aim at unravelling the mysteries of viral factories and dissecting the mechanisms of the late stages of RSV multiplication.
Respiratory syncytial virus (RSV) is a major public health issue. It is the main etiological agent of infant bronchiolitis and the most common cause of respiratory hospitalization of infants worldwide. In elderly or weakened subjects, its burden is comparable to that of seasonal influenza. To date, no curative antiviral drugs or vaccines have been commercialized. A better understanding of RSV multiplication mechanisms is necessary to meet this medical need.
Schematic illustration of the RSV multiplication steps that we are studying.
